Treatment of Posthemorrhagic Hydrocephalus

Susan Cohen; John Flibotte

doi:10.1016/j.clp.2021.11.002

Treatment of Posthemorrhagic Hydrocephalus

Clin Perinatol. 2022 Mar;49(1):15-25. doi: 10.1016/j.clp.2021.11.002. Epub 2022 Jan 21.

Authors

Susan Cohen¹, John Flibotte²

Affiliations

¹ Department of Pediatrics, Division of Neonatology, Medical College of Wisconsin, 999 North 92nd Street, CCC 410, Milwaukee, WI 53226, USA. Electronic address: scohen@mcw.edu.
² Department of Pediatrics, Division of Neonatology, Children's Hospital of Phildealphia & the Perelman School of Medicine at the University of Pennsylvania, 34th & Civic Center Boulevard, Philadelphia, PA 19104, USA.

PMID: 35209998
DOI: 10.1016/j.clp.2021.11.002

Abstract

The incidence of intraventricular hemorrhage (IVH) has overall declined to 15% to 20% of preterm infants with birth weight less than 1500 g. One of the major complications of severe IVH is posthemorrhagic ventricular dilation (PHVD). Nearly 10% of all infants with IVH and 20% of infants with severe IVH will develop progressive PHVD requiring surgical intervention to prevent parenchymal damage in the developing brain. This review focuses on the controversies regarding posthemorrhagic hydrocephalus interventions with a focus on how to interpret recent data from trials that some have seen as heralding a call toward more aggressive intervention.

Keywords: Intraventricular hemorrhage (IVH); Posthemorrhagic hydrocephalus (PHH); Posthemorrhagic ventricular dilation (PHVD).

Publication types

Review

MeSH terms

Cerebral Hemorrhage / complications
Cerebral Hemorrhage / therapy
Cerebral Ventricles
Humans
Hydrocephalus* / etiology
Hydrocephalus* / therapy
Incidence
Infant
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases* / epidemiology
Infant, Premature, Diseases* / therapy
Infant, Very Low Birth Weight